Clinical trials
Not yet recruiting Phase 1 Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Antengene Biologics Limited | 1 |
| AstraZeneca | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
| Changzhou No.2 People's Hospital | 1 |
| Chengdu Ucello Biotechnology Co., Ltd. | 1 |
| Children's Hospital of Fudan University | 1 |
| EdiGene Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 27 |
| Scleroderma, Systemic | 9 |
| Autoimmune Diseases | 7 |
| Myositis | 7 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5 |
| Sjogren's Syndrome | 5 |
| Arthritis, Rheumatoid | 3 |
| Scleroderma, Diffuse | 3 |
| Antiphospholipid Syndrome | 2 |
| Lupus Erythematosus, Cutaneous | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.